Keyphrases
Adenosine Analogue
16%
Adenosine nucleoside
100%
Antiretroviral Therapy
16%
Chain Terminator
16%
Compound Function
16%
Dengue Infection
16%
Dengue Virus
100%
Flavivirus
16%
Flavivirus Infection
16%
Hepatitis C Virus
16%
Human Infection
16%
In Vivo Pharmacokinetics
16%
Infected Mice
33%
Mosquito-borne Flavivirus
16%
NITD008
100%
NOAEL
33%
Nucleoside Inhibitors
100%
Oral Administration
16%
Pharmacokinetic Properties
16%
Potential Treatments
16%
Powassan Virus
16%
Public Health Risk
16%
RNA-dependent RNA Polymerase Activity
16%
Triphosphate
16%
Vesicular Stomatitis Virus
16%
Viral RNA Synthesis
16%
Viremia
16%
Virus
16%
Virus Yellows
16%
West Nile Virus
16%
Western Equine Encephalitis Virus
16%
Yellow Fever
16%
Pharmacology, Toxicology and Pharmaceutical Science
Adenosine
100%
Adenosine Derivative
14%
Antiviral Therapy
14%
Cytokine
14%
Dengue Virus
100%
Flavivirus
28%
Flavivirus Infection
14%
Hepatitis C Virus
14%
Infection
14%
No-Observed-Adverse-Effect Level
28%
Nucleoside
100%
Oral Administration
14%
Pharmacokinetics
14%
Powassan Virus
14%
RNA Directed RNA Polymerase
14%
Vesiculovirus
14%
Viremia
14%
Virus Infection
14%
Virus RNA
14%
West Nile Virus
14%
Western Equine Encephalitis Virus
14%
Yellow Fever Virus
14%